GJB2 is a priority candidate gene because it is responsible for up to 30% of congenital hearing loss.[64, 100] However, GJB2's broad expression in the cochlea and its human heterogeneity make it a challenging initial target. The gene discussed is GJB2; the disease is hearing loss disorder.